- 1Life scienceDog dewormer gets scarce amid rumors of efficacy in cancer
- 2PharmaHanmi spurs new immunotherapy development through open innovation
- 3PharmaNovo Nordisk releases trial result for basal insulin analog injection
- 4Pharma'Roche Korea to put patient accessibility first'
- 5PolicyRegulator finds no trace of carcinogen in GSK’s heartburn drug
- 6Bio‘Samsung BioLogics destroyed evidence to hide accounting fraud for months’
- 7PharmaOno Pharma, BMS unveil two P3 trial analyses for Opdivo